Catalyst Wire Dossier Catalyst Wire Dossier

mFOLFOX6 chemotherapy regimen

FOLFOX6 consisting of oxaliplatin, leucovorin, and 5-fluorouracil
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for mFOLFOX6 chemotherapy regimen, covering 2015-03-31 to 2026-01-27. Get the full timeline:

Most recent: Clinical Trial Update: A Pospective, Single-arm, Multicenter Clinical Trial Evaluating Preoperative Neoadjuvant mFOLFOX6 Chemotherapy in Combination With PD1 Monoclonal Antibody in MSS/pMMR Locally Advanced Rectal Cancer [NA]

See pricing